Biocon Limited (BIOCON) Stock Forecast & Price Target

Compare

14 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

BIOCON Analyst Ratings

Moderate Sell

1 Buy

0 Hold

3 Sell

Based on 4 analysts giving stock ratings to

Biocon

Limited

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

BIOCON Stock 12 Month Forecast

Average Price Target

₹361.75

▼(-0.67% Downside)

Based on 4 Wall Street analysts offering 12 month price targets for Biocon Limited in the last 3 months. The average price target is ₹361.75 with a high forecast of ₹435.00 and a low forecast of ₹312.00. The average price target represents a -0.67% change from the last price of ₹364.20.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"301":"₹301","436":"₹436","334.75":"₹334.8","368.5":"₹368.5","402.25":"₹402.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":435,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">₹435.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":361.75,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">₹361.75</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":312,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">₹312.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[301,334.75,368.5,402.25,436],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Mar<br/>2025","6":"Jun<br/>2025","9":"Sep<br/>2025","12":"Dec<br/>2025","25":"Dec<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,394.5,397.61538461538464,400.7307692307692,403.84615384615387,406.96153846153845,410.0769230769231,413.1923076923077,416.3076923076923,419.4230769230769,422.53846153846155,425.65384615384613,428.7692307692308,431.88461538461536,{"y":435,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,394.5,391.9807692307692,389.46153846153845,386.9423076923077,384.4230769230769,381.90384615384613,379.38461538461536,376.86538461538464,374.34615384615387,371.8269230769231,369.3076923076923,366.78846153846155,364.2692307692308,{"y":361.75,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,394.5,388.15384615384613,381.8076923076923,375.46153846153845,369.11538461538464,362.7692307692308,356.4230769230769,350.0769230769231,343.7307692307692,337.38461538461536,331.03846153846155,324.6923076923077,318.34615384615387,{"y":312,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":375.1,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":368.31,"date":1735689600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":362.06,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":302.2,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":338.7,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":321.27,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":333.6,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":361.87,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":382.95,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":352.55,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":346.5,"date":1759276800000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":372,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":394.5,"date":1764547200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target₹435.00

Average Price Target₹361.75

Lowest Price Target₹312.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Unknown Analyst

ICICI Securities

Not Ranked

ICICI Securities

₹380→₹350

Sell

-3.90%

Downside

Downgraded

12/10/25

ICICI Securities downgrades Biocon Limited (BIOCON) to a Sell

Damayanti Kerai

HSBC

₹415→₹435

Buy

19.44%

Upside

Reiterated

10/14/25

HSBC Sticks to Its Buy Rating for Biocon Limited (BIOCON)HSBC analyst Damayanti Kerai raised the price target on Biocon Ltd (BIOS:IN) to INR435.00 (from INR415.00) while maintaining a Buy rating.

Antu Eapan Thomas

Geojit Research

₹376→₹312

Sell

-14.33%

Downside

Downgraded

10/03/25

Biocon Limited (BIOCON) was downgraded to a Sell Rating at Geojit Research

Alankar Garude

Kotak Mahindra

₹350

Sell

-3.90%

Downside

Reiterated

09/29/25

Kotak Mahindra Keeps Their Sell Rating on Biocon Limited (BIOCON)

Shyam Srinivasan

Goldman Sachs

₹345→₹335

Hold

-8.02%

Downside

Reiterated

08/08/25

Goldman Sachs Sticks to Its Hold Rating for Biocon Limited (BIOCON)Goldman Sachs analyst Shyam Srinivasan lowered the price target on Biocon Ltd (BIOS:IN) to INR335.00 (from INR345.00) while maintaining a Neutral rating.

Anshuman Gupta CFA

Investec

₹400

Buy

9.83%

Upside

Initiated

05/15/25

Investec Starts Biocon Ltd (BIOS:IN) at BuyInvestec analyst Anshuman Gupta initiates coverage on Biocon Ltd (BIOS:IN) with a Buy rating and a price target of INR400.00.

Vivek Agrawal CFA

Citi

₹365→₹430

Buy

18.07%

Upside

Reiterated

02/03/25

Biocon Ltd (BIOS:IN) PT Raised to INR430 at CitiCiti analyst Vivek Agrawal raised the price target on Biocon Ltd (BIOS:IN) to INR430.00 (from INR365.00) while maintaining a Buy rating.

Alok Dalal

Jefferies

₹280→₹400

Hold

9.83%

Upside

Upgraded

01/06/25

Jefferies Upgrades Biocon Ltd (BIOS:IN) to HoldJefferies analyst Alok Dalal upgraded Biocon Ltd (BIOS:IN) from Underperform to Hold with a price target of INR400.00 (from INR280.00).

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Unknown Analyst

ICICI Securities

Not Ranked

ICICI Securities

₹380→₹350

Sell

-3.90%

Downside

Downgraded

12/10/25

ICICI Securities downgrades Biocon Limited (BIOCON) to a Sell

Damayanti Kerai

HSBC

₹415→₹435

Buy

19.44%

Upside

Reiterated

10/14/25

HSBC Sticks to Its Buy Rating for Biocon Limited (BIOCON)HSBC analyst Damayanti Kerai raised the price target on Biocon Ltd (BIOS:IN) to INR435.00 (from INR415.00) while maintaining a Buy rating.

Antu Eapan Thomas

Geojit Research

₹376→₹312

Sell

-14.33%

Downside

Downgraded

10/03/25

Biocon Limited (BIOCON) was downgraded to a Sell Rating at Geojit Research

Alankar Garude

Kotak Mahindra

₹350

Sell

-3.90%

Downside

Reiterated

09/29/25

Kotak Mahindra Keeps Their Sell Rating on Biocon Limited (BIOCON)

Shyam Srinivasan

Goldman Sachs

₹345→₹335

Hold

-8.02%

Downside

Reiterated

08/08/25

Anshuman Gupta CFA

Investec

₹400

Buy

9.83%

Upside

Initiated

05/15/25

Investec Starts Biocon Ltd (BIOS:IN) at BuyInvestec analyst Anshuman Gupta initiates coverage on Biocon Ltd (BIOS:IN) with a Buy rating and a price target of INR400.00.

Vivek Agrawal CFA

Citi

₹365→₹430

Buy

18.07%

Upside

Reiterated

02/03/25

Biocon Ltd (BIOS:IN) PT Raised to INR430 at CitiCiti analyst Vivek Agrawal raised the price target on Biocon Ltd (BIOS:IN) to INR430.00 (from INR365.00) while maintaining a Buy rating.

Alok Dalal

Jefferies

₹280→₹400

Hold

9.83%

Upside

Upgraded

01/06/25

Jefferies Upgrades Biocon Ltd (BIOS:IN) to HoldJefferies analyst Alok Dalal upgraded Biocon Ltd (BIOS:IN) from Underperform to Hold with a price target of INR400.00 (from INR280.00).

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Biocon Limited

1 Month

xxx

Success Rate

3/6 ratings generated profit

Average Return

+3.83%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 50.00% of your transactions generating a profit, with an average return of +3.83% per trade.

3 Months

xxx

Success Rate

4/6 ratings generated profit

Average Return

+0.70%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 66.67% of your transactions generating a profit, with an average return of +0.70% per trade.

1 Year

Damayanti KeraiHSBC

Success Rate

5/6 ratings generated profit

Average Return

+6.33%

reiterated a buy rating 2 months ago

Copying Damayanti Kerai's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +6.33% per trade.

2 Years

xxx

Success Rate

5/6 ratings generated profit

Average Return

+6.33%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +6.33% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

BIOCON Analyst Recommendation Trends

Rating

Aug 25

Sep 25

Oct 25

Nov 25

Dec 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, BIOCON has received 1 Buy Ratings, 3 Hold Ratings, and 2 Sell Ratings. BIOCON average Analyst price target in the past 3 months is 361.75.

Each month's total comprises the sum of three months' worth of ratings.

BIOCON Financial Forecast

BIOCON Earnings Forecast

Next quarter’s earnings estimate for BIOCON is ₹1.02 with a range of ₹1.02 to ₹1.02. The previous quarter’s EPS was ₹0.76. BIOCON beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year BIOCON has Performed in-line its overall industry.

BIOCON Sales Forecast

Next quarter’s sales forecast for BIOCON is ₹44.34B with a range of ₹43.23B to ₹45.45B. The previous quarter’s sales results were ₹42.95B. BIOCON beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year BIOCON has Performed in-line its overall industry.

BIOCON Stock Forecast FAQ

What is IN:BIOCON’s average 12-month price target, according to analysts?

Based on analyst ratings, Biocon Limited’s 12-month average price target is 361.75.

What is IN:BIOCON’s upside potential, based on the analysts’ average price target?

Currently there's no upside potential for IN:BIOCON, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Biocon Limited a Buy, Sell or Hold?

Biocon Limited has a consensus rating of Moderate Sell, which is based on 1 buy ratings, 0 hold ratings and 3 sell ratings.

What is Biocon Limited’s share price target?

The average share price target for Biocon Limited is 361.75. This is based on 4 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is ₹435.00 ,and the lowest forecast is ₹312.00. The average share price target represents -0.67% Decrease from the current price of ₹364.2.

What do analysts say about Biocon Limited?

Biocon Limited’s analyst rating consensus is a Moderate Sell. This is based on the ratings of 4 Wall Streets Analysts.

How can I buy shares of Biocon Limited?

To buy shares of IN:BIOCON, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Biocon Limited (BIOCON) Stock Forecast & Price Target

BIOCON Analyst Ratings

BIOCON Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Biocon Limited

BIOCON Analyst Recommendation Trends

BIOCON Financial Forecast

BIOCON Earnings Forecast

BIOCON Sales Forecast

BIOCON Stock Forecast FAQ

Detailed List of Analyst Forecasts